Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Powchik

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Archives of General Psychiatry|June 1, 1997
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophreniaS M Gabriel, V Haroutunian, P Powchik, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 1998
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenicsD J Healy, V Haroutunian, P Powchik, et al.
Biological Psychiatry|March 1, 1988
4-Aminopyridine in the treatment of Alzheimer's diseaseM Davidson, Z Zemishlany, R C Mohs, et al.
Archives of General Psychiatry|February 1, 1987
Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentrationM Davidson, A B Giordani, R C Mohs, et al.
Biological Psychiatry|June 5, 1998
Ventricular enlargement in poor-outcome schizophreniaK L Davis, M S Buchsbaum, L Shihabuddin, et al.
Biological Psychiatry|January 23, 1999
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patientsP D Harvey, J M Silverman, R C Mohs, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptomsR S Khan, F Amin, P Powchik, et al.
Genomics|November 1, 1989
Deletion mapping of DNA markers to a region of chromosome 5 that cosegregates with schizophreniaT C Gilliam, N B Freimer, C A Kaufmann, et al.
Biological Psychiatry|January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexS M Gabriel, M Davidson, V Haroutunian, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatientsM M Kincaid, P D Harvey, M Parrella, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Archives of General Psychiatry|June 1, 1997
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophreniaS M Gabriel, V Haroutunian, P Powchik, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 1998
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenicsD J Healy, V Haroutunian, P Powchik, et al.
Biological Psychiatry|March 1, 1988
4-Aminopyridine in the treatment of Alzheimer's diseaseM Davidson, Z Zemishlany, R C Mohs, et al.
Archives of General Psychiatry|February 1, 1987
Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentrationM Davidson, A B Giordani, R C Mohs, et al.
Biological Psychiatry|June 5, 1998
Ventricular enlargement in poor-outcome schizophreniaK L Davis, M S Buchsbaum, L Shihabuddin, et al.
Biological Psychiatry|January 23, 1999
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patientsP D Harvey, J M Silverman, R C Mohs, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptomsR S Khan, F Amin, P Powchik, et al.
Genomics|November 1, 1989
Deletion mapping of DNA markers to a region of chromosome 5 that cosegregates with schizophreniaT C Gilliam, N B Freimer, C A Kaufmann, et al.
Biological Psychiatry|January 15, 1996
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexS M Gabriel, M Davidson, V Haroutunian, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatientsM M Kincaid, P D Harvey, M Parrella, et al.
Pageof 4